Genomic research laboratory with scientists and advanced machinery
Months after an initial Series B tranche, Indian healthtech startup 4baseCare has announced the closure of its Series B funding round, raising an additional ₹38 Cr (approximately $4 Mn). This latest investment brings the total Series B funding to ₹128 Cr ($13 Mn). The round was led by growX Ventures, with participation from existing, undisclosed investors.
The capital infusion is earmarked for expanding 4baseCare’s genomics laboratory network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. A portion of the funds will also be dedicated to scaling its AI-driven precision oncology platform, OncoTwin, aimed at providing clinicians with actionable insights from real-world data.
“The additional capital will help us expand our genomics lab network globally and further scale OncoTwin, our AI-based precision oncology platform, to support clinicians with deeper, real-world, clinically actionable insights,” said Hitesh Goswami, cofounder and CEO of 4baseCare.
Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare utilizes advanced genomics, bioinformatics, and artificial intelligence to advance personalized oncology care. The company also focuses on building comprehensive databases that integrate genomic data with clinical, environmental, and lifestyle information to enhance precision medicine.
This funding follows a ₹90 Cr Series B investment received six months prior, co-led by investors Ashish Kacholia and Lashit Sanghvi. Previously, the Bengaluru-based startup secured ₹50 Cr in a Series A round led by Yali Capital in 2024.
The healthtech sector in India continues to attract significant investor interest, with a notable shift towards longevity, prevention, and continuous health optimization, often powered by AI and integrated platforms. Recent investments in the sector include StrainX Bioworks’ $13 Mn round and Cent’s $5 Mn seed funding. Biopeak also raised $2.7 Mn in January.
The Indian healthtech market is projected to reach $37 billion by 2030, underscoring the sector’s growth potential.
About the Author
